ERTS Wealth Advisors LLC increased its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 66.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,217 shares of the healthcare conglomerate’s stock after acquiring an additional 487 shares during the period. ERTS Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $297,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. Canton Hathaway LLC acquired a new stake in UnitedHealth Group in the 1st quarter valued at about $36,000. Coastal Capital Group Inc. acquired a new stake in UnitedHealth Group in the 2nd quarter valued at about $45,000. Creative Financial Designs Inc. ADV raised its position in UnitedHealth Group by 89.6% in the 1st quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock valued at $50,000 after purchasing an additional 95 shares in the last quarter. Capital Advisors Ltd. LLC raised its position in UnitedHealth Group by 235.7% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 235 shares of the healthcare conglomerate’s stock valued at $57,000 after purchasing an additional 165 shares in the last quarter. Finally, Financial Gravity Wealth Inc. acquired a new stake in UnitedHealth Group in the 1st quarter valued at about $58,000. 86.04% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities research analysts have issued reports on the company. ValuEngine lowered UnitedHealth Group from a “hold” rating to a “sell” rating in a research report on Thursday, September 5th. Cantor Fitzgerald set a $310.00 price target on UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Raymond James increased their price target on UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a research report on Friday, July 19th. Deutsche Bank assumed coverage on UnitedHealth Group in a research report on Thursday. They issued a “hold” rating and a $263.00 price target on the stock. Finally, Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price target on the stock in a research report on Monday, July 22nd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eighteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $292.47.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.46 by $0.14. The firm had revenue of $60.60 billion for the quarter, compared to the consensus estimate of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter last year, the business posted $3.14 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Inc will post 14.84 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be paid a dividend of $1.08 per share. The ex-dividend date of this dividend is Friday, September 13th. This represents a $4.32 dividend on an annualized basis and a yield of 1.84%. UnitedHealth Group’s dividend payout ratio is presently 33.54%.
In related news, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 8th. The stock was sold at an average price of $246.40, for a total transaction of $1,232,000.00. Following the transaction, the director now owns 187,979 shares in the company, valued at approximately $46,318,025.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy Patrick Flynn purchased 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The shares were purchased at an average price of $227.55 per share, for a total transaction of $455,100.00. Following the purchase, the director now directly owns 5,524 shares in the company, valued at $1,256,986.20. The disclosure for this purchase can be found here. Insiders have sold a total of 19,000 shares of company stock worth $4,758,720 in the last 90 days. 0.87% of the stock is currently owned by company insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: What is a Lock-Up Period?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.